Knowledge of the consequences of human Rcan1 overexpression is limited to evidence of genetic dysfunctions secondary to trisomy of chromosome 21 in patients with Down syndrome, who present defects of the immune system, though the prevalence of allergy is not high in these individuals (61). This evidence concerns the gene RCAN1 and allergic disease.